Inhaled nitric oxide: plenty of data, no consensus.
Cheifetz
I M
IM
D000328:Adult; D001993:Bronchodilator Agents / Q000191:economics / Q000627:therapeutic use*; D002170:Canada / Q000453:epidemiology; D002648:Child; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006801:Humans; D007231:Infant, Newborn; D009569:Nitric Oxide / Q000191:economics / Q000627:therapeutic use*; D012128:Respiratory Distress Syndrome / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D012138:Respiratory Therapy / Q000191:economics / Q000379:methods*; D015996:Survival Rate
D001993:Bronchodilator Agents; D009569:Nitric Oxide